A Study of the Efficacy of Botox in the Treatment of Social Anxiety Disorder

NCT03078270 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped study terminated due to low recruitment

Conditions

Anxiety Disorder Social
Anxiety

Interventions

DRUG: botulinum toxin A
OTHER: Placebo

Sponsor

Daniel Lieberman